- Report
- January 2026
- 187 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- September 2025
- 250 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- January 2026
- 185 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 184 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 185 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- August 2025
- 188 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 194 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 390 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 183 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 372 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 375 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 466 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 576 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- September 2025
- 250 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- August 2025
- 250 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- April 2025
- 175 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- April 2025
- 175 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- April 2025
- 200 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- March 2025
- 294 Pages
Global
From €3876EUR$4,490USD£3,358GBP
- Report
- March 2025
- 180 Pages
Global
From €3885EUR$4,500USD£3,365GBP

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals.
Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity.
Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more